Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate‐to‐severe glabellar lines: A non‐inferiority double blinded randomized controlled trial-Reference-Cited by-同舟云学术

Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate‐to‐severe glabellar lines: A non‐inferiority double blinded randomized controlled trial

Published:2022-04-09 Issue:6 Volume:21 Page:2398-2406
ISSN:1473-2130
Container-title:Journal of Cosmetic Dermatology
language:en
Short-container-title:J of Cosmetic Dermatology

Author:

Afshani Seyyedeh Maryam¹²,Samadi Aniseh³^ORCID,Ayatollahi Azin³,Kashani Mansour Nassiri³,Ahmad Nasdrollahi Saman³,Hosseini Hamed³⁴,Rezagholi Zahra¹²,Hedayatjoo Behnaz²,Hazegh Fetratjoo Delara¹²,Ghobadi Mohammad Amin¹,Anari AmirHossein¹²,Saeedifar Sajjad⁵,Firooz Alireza³⁴

Affiliation:

1. Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran

2. Medical Department Arta Pharmed Company Tehran Iran

3. Center for Research and Training in Skin diseases and Leprosy Tehran University of Medical Sciences Tehran Iran

4. Clinical Trial Center Tehran University of Medical Sciences Tehran Iran

5. Imen Vaccine Alborz Biotechnology Research Center Tehran Iran

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocd.14939